[go: up one dir, main page]

CN118241483A - Ribose cross-linked collagen fiber, and preparation and application thereof - Google Patents

Ribose cross-linked collagen fiber, and preparation and application thereof Download PDF

Info

Publication number
CN118241483A
CN118241483A CN202410361029.6A CN202410361029A CN118241483A CN 118241483 A CN118241483 A CN 118241483A CN 202410361029 A CN202410361029 A CN 202410361029A CN 118241483 A CN118241483 A CN 118241483A
Authority
CN
China
Prior art keywords
cross
ribose
collagen fibers
collagen
linked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202410361029.6A
Other languages
Chinese (zh)
Inventor
金磊
武彤彤
吴康健
王英杰
李体文
王宇欣
董欣
吴嘉
何晶晶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Aibairui Biotechnology Co ltd
Original Assignee
Beijing Aibairui Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Aibairui Biotechnology Co ltd filed Critical Beijing Aibairui Biotechnology Co ltd
Priority to CN202410361029.6A priority Critical patent/CN118241483A/en
Publication of CN118241483A publication Critical patent/CN118241483A/en
Pending legal-status Critical Current

Links

Classifications

    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M13/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
    • D06M13/10Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing oxygen
    • D06M13/144Alcohols; Metal alcoholates
    • D06M13/148Polyalcohols, e.g. glycerol or glucose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/06Flowable or injectable implant compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/34Materials or treatment for tissue regeneration for soft tissue reconstruction
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M2101/00Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
    • D06M2101/02Natural fibres, other than mineral fibres
    • D06M2101/10Animal fibres
    • D06M2101/14Collagen fibres

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention provides a ribose cross-linked collagen fiber, which is formed by cross-linking collagen fiber with ribose as a cross-linking agent, wherein the diameter of the collagen fiber is 15-80 nm; the diameter of the ribose cross-linked collagen fiber is between 150 and 200 nm; the crosslinking degree of the ribose crosslinked collagen fiber is between 40.7 and 56.1 percent; tm value = 58.54 ℃ -66.46 ℃. The invention also provides a preparation method and application of the ribose cross-linked collagen fiber. The ribose cross-linked collagen fiber provided by the invention has lower thrust and collagenase degradation resistance. The crosslinking agent used in the invention is natural ribose without any toxic side effect, and has better biocompatibility compared with other crosslinking forms.

Description

核糖交联胶原蛋白纤维及其制备和应用Ribose cross-linked collagen fibers and their preparation and application

技术领域Technical Field

本发明涉及一种核糖交联胶原蛋白纤维及其制备和应用。The invention relates to ribose cross-linked collagen fiber and the preparation and application thereof.

背景技术Background Art

随着年龄的增长,体内的胶原蛋白含量逐渐减少,会出现皮肤松弛、皱纹增多、关节疼痛等问题。因此,如何补充胶原蛋白一直备受美容和健康保健领域的关注。高纯度的动物源性胶原蛋白具有良好生物相容性,可以作为组织填充剂使用。然而由于体内胶原酶的存在,临床使用发现天然胶原蛋白在体内存在维持时间3-6个月。为了增加胶原蛋白填充剂在体内的保留时间,戊二醛,还原糖,环氧化物交联剂和亚胺类交联剂已经被用于胶原蛋白交联以制备更稳定,体内保留时间更长的胶原蛋白填充剂。最早应用于临床除皱的交联胶原蛋白填充剂产品collagen implants和目前已获批上市的双美科技有限公司的交联胶原蛋白产品“肤丽美”采用戊二醛作为交联剂,已获批的交联胶原蛋白填充剂产品还有Col Bar Life Science Ltd.公司以核糖为交联剂开发的其他类型交联剂目前没有相应产品获批,其生物安全性有待临床实验进一步验证。这些产品他们的一个共同的特点是首先在中性条件下进行纤维化制备胶原蛋白纤维然后进行交联反应。其中还原糖交联是模拟生理条件下胶原蛋白纤维和还原性葡萄糖相互作用导致的胶原蛋白纤维交联稳定化反应。还原糖与胶原蛋白纤维的赖氨酸和羟赖氨酸残基上ε-氨基团之间形成席夫碱(Schiffbase),席夫碱经Amadori重排和一系列的进一步反应形成胶原分子间的不可逆稳定交联。由于核糖交联剂为无任何毒性副作用的天然还原糖,相比于其他交联形式,其具有更好的生物相容性。然而核糖交联胶原蛋白效率低,反应时间长(US 6,682,760 B2)。我们认为通过调控纤维化过程和胶原分子组装排列可以提高核糖交联胶原蛋白纤维的交联效率和耐胶原酶降解能力。As we age, the collagen content in the body gradually decreases, and problems such as sagging skin, increased wrinkles, and joint pain will occur. Therefore, how to supplement collagen has always been a concern in the field of beauty and health care. High-purity animal-derived collagen has good biocompatibility and can be used as a tissue filler. However, due to the presence of collagenase in the body, clinical use has found that natural collagen only exists in the body for 3-6 months. In order to increase the retention time of collagen fillers in the body, glutaraldehyde, reducing sugars, epoxide crosslinkers and imine crosslinkers have been used to crosslink collagen to prepare more stable collagen fillers with longer retention time in the body. The earliest cross-linked collagen filler product used in clinical wrinkle removal Collagen implants and the cross-linked collagen product "Fu Li Mei" by Shuangmei Technology Co., Ltd., which has been approved for marketing, use glutaraldehyde as a cross-linking agent. Other approved cross-linked collagen filler products include Col Bar Life Science Ltd., which uses ribose as a cross-linking agent. Currently, no corresponding products of other types of cross-linking agents have been approved, and their biosafety needs to be further verified in clinical trials. A common feature of these products is that they first prepare collagen fibers by fibrosis under neutral conditions and then undergo cross-linking reactions. Among them, reducing sugar cross-linking is a cross-linking and stabilization reaction of collagen fibers caused by the interaction between collagen fibers and reducing glucose under simulated physiological conditions. Reducing sugars form Schiff bases between the ε-amino groups on the lysine and hydroxylysine residues of collagen fibers. The Schiff bases undergo Amadori rearrangement and a series of further reactions to form irreversible stable cross-links between collagen molecules. Since ribose cross-linkers are natural reducing sugars without any toxic side effects, they have better biocompatibility than other cross-linking forms. However, ribose cross-linking of collagen is inefficient and takes a long time to react (US 6,682,760 B2). We believe that the cross-linking efficiency and resistance to collagenase degradation of ribose cross-linked collagen fibers can be improved by regulating the fibrosis process and the assembly and arrangement of collagen molecules.

发明内容Summary of the invention

为了提高核糖交联胶原蛋白纤维的交联效率和耐胶原酶降解能力,增加交联胶原蛋白纤维的交联度和熔点,本发明提供一种新的核糖交联胶原蛋白纤维,可用于填充剂。In order to improve the cross-linking efficiency and resistance to collagenase degradation of ribose cross-linked collagen fibers, and increase the cross-linking degree and melting point of the cross-linked collagen fibers, the present invention provides a new ribose cross-linked collagen fiber that can be used as a filler.

作为本发明的一个方面,核糖交联胶原蛋白纤维,由胶原蛋白纤维以核糖为交联剂交联而成;所述胶原蛋白纤维直径在15-80nm之间;所述核糖交联胶原蛋白纤维直径在150-200nm之间;所述核糖交联胶原蛋白纤维的交联度在40.7%-56.1%之间,优选48.6%-56.1%;熔点Tm值=58.54℃-66.46℃,优选Tm值=59.59℃-66.46℃。As one aspect of the present invention, ribose cross-linked collagen fibers are formed by cross-linking collagen fibers using ribose as a cross-linking agent; the diameter of the collagen fibers is between 15-80nm; the diameter of the ribose cross-linked collagen fibers is between 150-200nm; the cross-linking degree of the ribose cross-linked collagen fibers is between 40.7%-56.1%, preferably 48.6%-56.1%; the melting point Tm value = 58.54℃-66.46℃, preferably Tm value = 59.59℃-66.46℃.

作为本发明的另一个方面,涉及一种交联胶原蛋白纤维填充剂,所述填充剂含有上述核糖交联胶原蛋白纤维。所述填充剂还可以含有利多卡因。As another aspect of the present invention, it relates to a cross-linked collagen fiber filler, wherein the filler contains the above-mentioned ribose cross-linked collagen fiber and may further contain lidocaine.

作为本发明的又一个方面,涉及制备上述交联胶原蛋白填充剂的方法,其特征在于,所述方法包括:使用生理盐水调节蛋白浓度35mg/mL,利多卡因浓度0.2%,匀浆后无菌灌装于1mL规格的针管中,密封。As another aspect of the present invention, it relates to a method for preparing the above-mentioned cross-linked collagen filler, characterized in that the method comprises: using physiological saline to adjust the protein concentration to 35 mg/mL and the lidocaine concentration to 0.2%, and after homogenization, aseptically filling into a 1 mL syringe and sealing.

作为本发明的又一个方面,涉及制备上述核糖交联胶原蛋白纤维的方法,包括:As another aspect of the present invention, it relates to a method for preparing the above-mentioned ribose cross-linked collagen fibers, comprising:

去除免疫原性和病毒的纯化胶原蛋白分子酸性条件下纤维化后进行核糖交联,其中,酸性条件pH值5.0-6.0,核糖浓度1%-5%(w:v)。The purified collagen molecules from which immunogenicity and virus are removed are fibrotic under acidic conditions and then cross-linked with ribose, wherein the pH value of the acidic conditions is 5.0-6.0 and the ribose concentration is 1%-5% (w:v).

由本发明实施例可知,本发明在酸性条件下制备得到直径较小的胶原蛋白纤维,经核糖交联后具有良好的热稳定性和耐胶原酶降解能力,可以维持较长的降解周期。这些性能的综合展示,使得本发明所制备的核糖交联胶原蛋白纤维可以作为填充剂配合利多卡因用于整形外科等领域。而且核糖交联胶原蛋白纤维具有较低的推力和良好的生物相容性,保证产品的安全性并适合用于注射填充。It can be seen from the embodiments of the present invention that the present invention prepares collagen fibers with a smaller diameter under acidic conditions, and has good thermal stability and resistance to collagenase degradation after ribose cross-linking, and can maintain a longer degradation cycle. The comprehensive display of these properties enables the ribose cross-linked collagen fibers prepared by the present invention to be used as a filler in combination with lidocaine in the fields of plastic surgery. In addition, the ribose cross-linked collagen fibers have lower thrust and good biocompatibility, ensuring the safety of the product and being suitable for injection filling.

具体实施方式DETAILED DESCRIPTION

本申请由北京艾佰瑞生物技术有限公司和北京佰仁医疗科技股份有限公司共同参与研发。This application was jointly developed by Beijing Aibairui Biotechnology Co., Ltd. and Beijing Bairen Medical Technology Co., Ltd.

发明人在参照现有技术进行实验的过程发现,中性条件制备的胶原蛋白纤维直径大,核糖交联剂虽然能提高胶原蛋白纤维的熔点,提升耐胶原酶降解能力,但是交联反应效率低,反应时间长(US 6,682,760 B2)。CN114288469A报道中性条件制备的胶原蛋白纤维经核糖交联后使用碳二亚胺进行双重交联,进一步提高交联胶原蛋白纤维的熔点。但是双重交联降低了单一核糖交联胶原蛋白纤维的生物安全性。CN108752604将胶原蛋白分子(分子量5-30万)在离子溶液升温溶解,降温再生后进行核糖交联,增加胶原蛋白溶解度,缩短交联时间,提升交联效率,然而胶原蛋白经高温离子溶液处理后容易发生蛋白变性,失去蛋白本身的功能活性。普遍认为酸性条件下形成的胶原蛋白纤维直径较小,不能满足作为填充剂的要求。但经过进一步实验,发明人惊奇地发现,只要对酸性条件下制备胶原蛋白纤维的工艺过程进行控制,所制备的胶原蛋白纤维可以均匀地与核糖反应形成共价键,反应效率提高,核糖交联胶原蛋白纤维的熔点和交联度明显提升,经进一步处理后,可用于填充剂。The inventor found in the process of experimenting with reference to the prior art that the collagen fiber prepared under neutral conditions has a large diameter. Although the ribose cross-linking agent can improve the melting point of the collagen fiber and enhance the ability to resist collagenase degradation, the cross-linking reaction efficiency is low and the reaction time is long (US 6,682,760 B2). CN114288469A reports that the collagen fiber prepared under neutral conditions is double-crosslinked using carbodiimide after ribose cross-linking, further improving the melting point of the cross-linked collagen fiber. However, double cross-linking reduces the biosafety of single ribose cross-linked collagen fiber. CN108752604 dissolves collagen molecules (molecular weight 5-300,000) in ionic solution by heating, and performs ribose cross-linking after cooling and regeneration, increasing collagen solubility, shortening cross-linking time, and enhancing cross-linking efficiency, but collagen is prone to protein denaturation after being treated with high-temperature ionic solution, and loses the functional activity of the protein itself. It is generally believed that the collagen fiber diameter formed under acidic conditions is relatively small and cannot meet the requirements as a filler. However, after further experiments, the inventors surprisingly found that as long as the process of preparing collagen fibers under acidic conditions is controlled, the prepared collagen fibers can react with ribose evenly to form covalent bonds, the reaction efficiency is improved, and the melting point and cross-linking degree of ribose-cross-linked collagen fibers are significantly improved. After further processing, they can be used as fillers.

本申请所称中性条件是指pH值6.5-7.5,本申请所称酸性条件是指pH值5.0-6.0。The neutral conditions referred to in this application refer to a pH value of 6.5-7.5, and the acidic conditions referred to in this application refer to a pH value of 5.0-6.0.

本申请所称的胶原蛋白纤维指的是:胶原蛋白分子经过磷酸盐、NaCl纤维化反应后的产物,中性条件下反应以直径80-200nm的胶原蛋白纤维为主要成分,酸性条件下反应以直径15-30nm的胶原蛋白纤维为主要成分。The collagen fibers referred to in this application refer to: the product of collagen molecules after phosphate and NaCl fibrillation reaction. Under neutral conditions, the reaction has collagen fibers with a diameter of 80-200nm as the main component, and under acidic conditions, the reaction has collagen fibers with a diameter of 15-30nm as the main component.

本申请所称的核糖交联胶原蛋白纤维指的是:胶原蛋白纤维经过核糖交联反应后离心清洗得到的产物。The ribose-crosslinked collagen fibers referred to in the present application refer to products obtained by centrifugation and washing after the collagen fibers undergo ribose crosslinking reaction.

本发明对所制备的核糖交联胶原蛋白纤维进行熔点测试的方法如下:The method for testing the melting point of the prepared ribose cross-linked collagen fibers is as follows:

定量转移核糖交联胶原蛋白纤维至差式扫描量热仪的测试铝坩埚中,然后封置于差示扫描量热仪中,氮气气氛下,10K/min升温温度,在升温范围25℃-100℃条件下进行扫描测定。The ribose cross-linked collagen fibers were quantitatively transferred to the test aluminum crucible of the differential scanning calorimeter, and then sealed in the differential scanning calorimeter. The temperature was increased at 10K/min under a nitrogen atmosphere and the scanning measurement was performed in the temperature range of 25°C-100°C.

本发明对所制备的核糖交联胶原蛋白纤维进行交联度测试的方法如下:The method for testing the cross-linking degree of the prepared ribose cross-linked collagen fibers is as follows:

定量转移核糖交联胶原蛋白纤维至微型离心管,配制0.1M pH 8.5NaHCO3溶液和0.5%(v:v)TNBS溶液,取配制好的两种溶液各1mL先后加入核糖交联胶原蛋白纤维中,40℃反应2小时。反应结束后,加入3mL,6M HCl,60℃反应1.5小时,反应结束冷却至室温后,加入5mL去离子水混合均匀。取出5mL混合液加入乙醚,震荡后静置分层并取出乙醚。添加新的乙醚重复3次后,待反应液中乙醚完全挥发,取出200μL反应液并加入400μL去离子水,混匀后使用酶标仪测试345nm吸光度值,减去空白组的吸光度值后得到吸光度值A。取等量未交联的胶原蛋白纤维重复上述步骤得到吸光度值B,利用以下公式计算核糖交联胶原蛋白纤维交联度:Quantitatively transfer ribose cross-linked collagen fibers to a microcentrifuge tube, prepare 0.1M pH 8.5 NaHCO 3 solution and 0.5% (v:v) TNBS solution, take 1mL of each of the two prepared solutions and add them to the ribose cross-linked collagen fibers, and react at 40°C for 2 hours. After the reaction is completed, add 3mL, 6M HCl, react at 60°C for 1.5 hours, cool to room temperature after the reaction, add 5mL of deionized water and mix evenly. Take out 5mL of the mixed solution and add ether, shake it and let it stand to separate and take out the ether. After adding new ether three times, wait for the ether in the reaction solution to completely evaporate, take out 200μL of the reaction solution and add 400μL of deionized water, mix well, and use an enzyme reader to test the 345nm absorbance value, and subtract the absorbance value of the blank group to obtain the absorbance value A. Take an equal amount of uncross-linked collagen fibers and repeat the above steps to obtain the absorbance value B, and calculate the cross-linking degree of ribose cross-linked collagen fibers using the following formula:

本发明对所制备的核糖交联胶原蛋白纤维进行体外胶原酶降解测试的方法如下:The method of the present invention for conducting an in vitro collagenase degradation test on the prepared ribose cross-linked collagen fibers is as follows:

定量转移一定量核糖交联胶原蛋白纤维至微型离心管,配制50mM pH 7.4TES胶原酶反应缓冲液,再将核糖交联胶原蛋白纤维在TES溶液中配制成2-5mg/ml悬浊液,根据核糖交联胶原蛋白纤维总量加入胶原酶溶液,添加比例为1.25U/mg,37℃消化24小时将样品离心收集沉淀和上清液,通过酶标仪测定羟脯氨酸含量计算沉淀和上清液中胶原含量。参照McPherson et al.(1986)Journal ofBiomedical Material Research,20:79-92.利用以下公式计算核糖交联胶原蛋白纤维的体外胶原酶降解率:Quantitatively transfer a certain amount of ribose cross-linked collagen fibers to a microcentrifuge tube, prepare 50mM pH 7.4 TES collagenase reaction buffer, and then prepare the ribose cross-linked collagen fibers into a 2-5mg/ml suspension in the TES solution. Add collagenase solution according to the total amount of ribose cross-linked collagen fibers, and the addition ratio is 1.25U/mg. Digest at 37°C for 24 hours, centrifuge the sample to collect the precipitate and supernatant, and calculate the collagen content in the precipitate and supernatant by measuring the hydroxyproline content with an ELISA reader. Referring to McPherson et al. (1986) Journal of Biomedical Material Research, 20: 79-92. The in vitro collagenase degradation rate of ribose cross-linked collagen fibers was calculated using the following formula:

实施例1:中性条件制备核糖交联胶原蛋白纤维Example 1: Preparation of ribose cross-linked collagen fibers under neutral conditions

(1)动物源性组织预处理(本步骤可以参照现有技术实施):取新鲜猪皮组织刮去表面脂肪后,将其浸泡在丙酮溶液,室温浸泡16h,将处理后的材料用去离子水清洗3-5次除去多余丙酮,再将材料放入2.0M NaOH溶液中,室温,搅拌,16h,处理结束后用去离子水浸泡,清洗材料至中性,以达到去脂和病毒灭活。(1) Animal-derived tissue pretreatment (this step can be implemented with reference to the prior art): Take fresh pig skin tissue and scrape off the surface fat, then soak it in an acetone solution at room temperature for 16 hours. Wash the treated material with deionized water for 3-5 times to remove excess acetone, and then put the material into a 2.0M NaOH solution at room temperature with stirring for 16 hours. After the treatment, soak the material in deionized water and wash it until it is neutral to achieve fat removal and virus inactivation.

(2)提取(本步骤可以参照现有技术实施):将清洗后的材料放入0.5M乙酸中进行破碎,匀浆。匀浆后的组织按20:1(组织重量/胃蛋白酶重量)的比例进行胶原蛋白分子提取,控制温度18℃,搅拌提取72小时。将提取液离心收集上清,并搅拌均匀后进行澄清过滤,控制浊度小于30,得到胶原蛋白分子粗提液。(2) Extraction (this step can be implemented with reference to the prior art): The cleaned material is placed in 0.5M acetic acid for crushing and homogenization. The homogenized tissue is subjected to collagen molecule extraction at a ratio of 20:1 (tissue weight/pepsin weight), the temperature is controlled at 18°C, and the extraction is stirred for 72 hours. The extract is centrifuged to collect the supernatant, and after stirring evenly, it is clarified and filtered, and the turbidity is controlled to be less than 30 to obtain a crude collagen molecule extract.

(3)超滤纯化(本步骤可以参照现有技术实施):利用切向流系统进行超滤胶原蛋白分子粗提液,浓缩至3mg/ml后,开始进行20mM乙酸溶液透析,透析20倍体积后得到胶原蛋白分子。(3) Ultrafiltration purification (this step can be implemented with reference to the prior art): Use a tangential flow system to ultrafilter the crude collagen molecule extract, concentrate it to 3 mg/ml, and then start dialysis with 20 mM acetic acid solution. After dialysis of 20 times the volume, the collagen molecule is obtained.

(4)胶原蛋白分子纤维化:取一定体积的纯化后胶原蛋白分子,加入1/10体积的磷酸盐缓冲液(0.2M Na2HPO4:0.2M NaH2PO4=7:3,v:v)。混匀调pH为7.0,30℃放置6小时得到胶原蛋白纤维。90%胶原蛋白纤维直径在80-200nm之间。(4) Collagen molecule fibrillation: Take a certain volume of purified collagen molecules and add 1/10 volume of phosphate buffer (0.2M Na 2 HPO 4 :0.2M NaH 2 PO 4 =7:3, v:v). Mix well and adjust the pH to 7.0, and place at 30°C for 6 hours to obtain collagen fibers. 90% of the collagen fibers have a diameter between 80-200 nm.

(5)胶原蛋白纤维交联:将胶原蛋白纤维离心得到沉淀后,加入10倍体积的0.5%(w:v)D-核糖-磷酸盐缓冲液,混匀后37℃放置继续搅拌15天。离心收集沉淀,pH7.0磷酸盐缓冲液清洗3次即得核糖交联胶原蛋白纤维。70%核糖交联胶原蛋白纤维直径在150-200nm之间,并形成网状结构。(5) Collagen fiber cross-linking: After the collagen fibers are centrifuged to obtain a precipitate, 10 volumes of 0.5% (w:v) D-ribose-phosphate buffer are added, mixed and placed at 37°C for 15 days. The precipitate is collected by centrifugation and washed three times with pH 7.0 phosphate buffer to obtain ribose cross-linked collagen fibers. The diameter of 70% ribose cross-linked collagen fibers is between 150-200 nm and forms a mesh structure.

(6)灌装:取一定体积的核糖交联胶原蛋白纤维,进行8000rpm,30min离心,得到的沉淀加入生理盐水匀浆后将浓度调节为35mg/ml,再将调节好浓度的核糖交联胶原蛋白纤维无菌灌装于1mL规格的针管中,密封,得到核糖交联胶原蛋白纤维填充剂。(6) Filling: Take a certain volume of ribose cross-linked collagen fibers and centrifuge at 8000 rpm for 30 min. After adding physiological saline to the obtained precipitate for homogenization, adjust the concentration to 35 mg/ml. Then, aseptically fill the ribose cross-linked collagen fibers with the adjusted concentration into a 1 mL syringe and seal it to obtain the ribose cross-linked collagen fiber filler.

本实施例获得的核糖交联胶原蛋白纤维利用差式扫描量热仪和酶标仪检测,Tm值=56.05℃,交联度30.4%。体外胶原酶处理后降解率85%。进一步通过推拉力试验机检测其物理性能:27G针头,以1mL/min速度进行测试,推力为6.13N。The ribose cross-linked collagen fibers obtained in this example were tested by differential scanning calorimetry and microplate reader, with a Tm value of 56.05°C and a cross-linking degree of 30.4%. The degradation rate after in vitro collagenase treatment was 85%. The physical properties were further tested by a push-pull tester: 27G needle, tested at a speed of 1mL/min, with a thrust of 6.13N.

实施例2:中性条件制备核糖交联胶原蛋白纤维Example 2: Preparation of ribose cross-linked collagen fibers under neutral conditions

步骤(1)-(3)同实施例1。Steps (1) to (3) are the same as in Example 1.

(4)胶原蛋白分子纤维化:取一定体积的纯化后胶原蛋白分子,加入1/10体积的磷酸盐缓冲液(0.2M Na2HPO4:0.2M NaH2PO4=7:3,v:v)。混匀调pH为7.0,30℃放置6小时得到胶原蛋白纤维。90%胶原蛋白纤维直径在80-200nm之间。(4) Collagen molecule fibrillation: Take a certain volume of purified collagen molecules and add 1/10 volume of phosphate buffer (0.2M Na 2 HPO 4 :0.2M NaH 2 PO 4 =7:3, v:v). Mix well and adjust the pH to 7.0, and place at 30°C for 6 hours to obtain collagen fibers. 90% of the collagen fibers have a diameter between 80-200 nm.

(5)胶原蛋白纤维交联:将胶原蛋白纤维离心得到沉淀后,加入10倍体积的1%(w:v)D-核糖-磷酸盐缓冲液,混匀后37℃放置继续搅拌15天。离心收集沉淀,pH7.0磷酸盐缓冲液清洗3次即得核糖交联胶原蛋白纤维。80%核糖交联胶原蛋白纤维直径在150-200nm之间,并形成网状结构。(5) Collagen fiber cross-linking: After the collagen fibers are centrifuged to obtain a precipitate, 10 times the volume of 1% (w:v) D-ribose-phosphate buffer is added, mixed and placed at 37°C for 15 days. The precipitate is collected by centrifugation and washed three times with pH 7.0 phosphate buffer to obtain ribose cross-linked collagen fibers. The diameter of 80% ribose cross-linked collagen fibers is between 150-200 nm and forms a network structure.

步骤(6)同实施例1。Step (6) is the same as in Example 1.

本实施例获得的核糖交联胶原蛋白纤维利用差式扫描量热仪和酶标仪检测,Tm值=56.68℃,交联度31.2%。体外胶原酶处理后降解率82%。进一步通过推拉力试验机检测其物理性能:27G针头,以1mL/min速度进行测试,推力为6.26N。The ribose cross-linked collagen fibers obtained in this example were tested by differential scanning calorimetry and microplate reader, and the Tm value was 56.68°C, and the cross-linking degree was 31.2%. The degradation rate after in vitro collagenase treatment was 82%. The physical properties were further tested by a push-pull tester: 27G needle, tested at a speed of 1mL/min, and the thrust was 6.26N.

实施例3:中性条件制备核糖交联胶原蛋白纤维Example 3: Preparation of ribose cross-linked collagen fibers under neutral conditions

步骤(1)-(3)同实施例1。Steps (1) to (3) are the same as in Example 1.

(4)胶原蛋白分子纤维化:取一定体积的纯化后胶原蛋白分子,加入1/10体积的磷酸盐缓冲液(0.2M Na2HPO4:0.2M NaH2PO4=7:3,v:v)。混匀调pH为7.0,30℃放置6小时得到胶原蛋白纤维。90%胶原蛋白纤维直径在80-200nm之间。(4) Collagen molecule fibrillation: Take a certain volume of purified collagen molecules and add 1/10 volume of phosphate buffer (0.2M Na 2 HPO 4 :0.2M NaH 2 PO 4 =7:3, v:v). Mix well and adjust the pH to 7.0, and place at 30°C for 6 hours to obtain collagen fibers. 90% of the collagen fibers have a diameter between 80-200 nm.

(5)胶原蛋白纤维交联:将胶原蛋白纤维离心得到沉淀后,加入10倍体积的3%(w:v)D-核糖-磷酸盐缓冲液,混匀后37℃放置继续搅拌15天。离心收集沉淀,pH7.0磷酸盐缓冲液清洗3次即得核糖交联胶原蛋白纤维。90%核糖交联胶原蛋白纤维直径在150-200nm之间,并形成网状结构。(5) Collagen fiber cross-linking: After the collagen fibers are centrifuged to obtain a precipitate, 10 volumes of 3% (w:v) D-ribose-phosphate buffer are added, mixed and placed at 37°C for 15 days. The precipitate is collected by centrifugation and washed three times with pH 7.0 phosphate buffer to obtain ribose cross-linked collagen fibers. The diameter of 90% ribose cross-linked collagen fibers is between 150-200 nm and forms a mesh structure.

步骤(6)同实施例1。Step (6) is the same as in Example 1.

本实施例获得的核糖交联胶原蛋白纤维利用差式扫描量热仪和酶标仪检测,Tm值=57.28℃,交联度34%。体外胶原酶处理后降解率73%。进一步通过推拉力试验机检测其物理性能:27G针头,以1mL/min速度进行测试,推力为6.89N。The ribose cross-linked collagen fibers obtained in this example were tested by differential scanning calorimetry and microplate reader, and the Tm value was 57.28°C, and the cross-linking degree was 34%. The degradation rate after in vitro collagenase treatment was 73%. The physical properties were further tested by a push-pull tester: 27G needle, tested at a speed of 1mL/min, and the thrust was 6.89N.

实施例4:中性条件制备核糖交联胶原蛋白纤维Example 4: Preparation of ribose cross-linked collagen fibers under neutral conditions

步骤(1)-(3)同实施例1。Steps (1) to (3) are the same as in Example 1.

胶原蛋白分子纤维化:取一定体积的纯化后胶原蛋白分子,加入1/10体积的磷酸盐缓冲液(0.2M Na2HPO4:0.2M NaH2PO4=7:3,v:v)。混匀调pH为7.0,30℃放置6小时得到胶原蛋白纤维。90%胶原蛋白纤维直径在80-200nm之间。Collagen molecule fibrillation: Take a certain volume of purified collagen molecules, add 1/10 volume of phosphate buffer (0.2M Na 2 HPO 4 :0.2M NaH 2 PO 4 =7:3, v:v). Mix well and adjust pH to 7.0, place at 30°C for 6 hours to obtain collagen fibers. 90% of the collagen fibers have a diameter between 80-200nm.

(5)胶原蛋白纤维交联:将胶原蛋白纤维离心得到沉淀后,加入10倍体积的5%(w:v)D-核糖-磷酸盐缓冲液,混匀后37℃放置继续搅拌15天。离心收集沉淀,pH7.0磷酸盐缓冲液清洗3次即得核糖交联胶原蛋白纤维。90%核糖交联胶原蛋白纤维直径在150-200nm之间,并形成网状结构。(5) Collagen fiber cross-linking: After the collagen fibers are centrifuged to obtain a precipitate, 10 volumes of 5% (w:v) D-ribose-phosphate buffer solution are added, mixed and placed at 37°C for 15 days. The precipitate is collected by centrifugation and washed three times with pH 7.0 phosphate buffer to obtain ribose cross-linked collagen fibers. The diameter of 90% ribose cross-linked collagen fibers is between 150-200 nm and forms a mesh structure.

步骤(6)同实施例1。Step (6) is the same as in Example 1.

本实施例获得的核糖交联胶原蛋白纤维利用差式扫描量热仪和酶标仪检测,Tm值=56.76℃,交联度32.8%。体外胶原酶处理后降解率75%。进一步通过推拉力试验机检测其物理性能:27G针头,以1mL/min速度进行测试,推力为6.43N。The ribose cross-linked collagen fibers obtained in this example were tested by differential scanning calorimetry and microplate reader, with a Tm value of 56.76°C and a cross-linking degree of 32.8%. The degradation rate after in vitro collagenase treatment was 75%. The physical properties were further tested by a push-pull tester: 27G needle, tested at a speed of 1mL/min, with a thrust of 6.43N.

实施例5:酸性条件制备核糖交联胶原蛋白纤维Example 5: Preparation of ribose cross-linked collagen fibers under acidic conditions

步骤(1)-(3)同实施例1。Steps (1) to (3) are the same as in Example 1.

(4)胶原蛋白分子纤维化:取一定体积的纯化后胶原蛋白分子,加入1/10体积的磷酸盐缓冲液(0.2M Na2HPO4:0.2M NaH2PO4=7:3,v:v)。混匀调pH为6.0,30℃放置6小时得到胶原蛋白纤维。70%胶原蛋白纤维直径50-80nm。(4) Collagen molecule fibrillation: Take a certain volume of purified collagen molecules and add 1/10 volume of phosphate buffer (0.2M Na 2 HPO 4 :0.2M NaH 2 PO 4 =7:3, v:v). Mix well and adjust the pH to 6.0, and place at 30°C for 6 hours to obtain collagen fibers. 70% of the collagen fibers have a diameter of 50-80nm.

(5)胶原蛋白纤维交联:将胶原蛋白纤维离心得到沉淀后,加入10倍体积的1%(w:v)D-核糖-磷酸盐缓冲液,混匀后37℃放置继续搅拌15天。离心收集沉淀,pH7.0磷酸盐缓冲液清洗3次即得核糖交联胶原蛋白纤维。80%核糖交联胶原蛋白纤维直径在150-200nm之间,并形成网状结构。(5) Collagen fiber cross-linking: After the collagen fibers are centrifuged to obtain a precipitate, 10 times the volume of 1% (w:v) D-ribose-phosphate buffer is added, mixed and placed at 37°C for 15 days. The precipitate is collected by centrifugation and washed three times with pH 7.0 phosphate buffer to obtain ribose cross-linked collagen fibers. The diameter of 80% ribose cross-linked collagen fibers is between 150-200 nm and forms a network structure.

步骤(6)同实施例1。Step (6) is the same as in Example 1.

本实施例获得的核糖交联胶原蛋白纤维利用差式扫描量热仪和酶标仪检测,Tm值=58.54℃,交联度40.7%。体外胶原酶处理后降解率58%。进一步通过推拉力试验机检测其物理性能:27G针头,以1mL/min速度进行测试,推力为5.68N。The ribose cross-linked collagen fibers obtained in this example were tested by differential scanning calorimetry and microplate reader, and the Tm value was 58.54°C, and the cross-linking degree was 40.7%. The degradation rate after in vitro collagenase treatment was 58%. The physical properties were further tested by a push-pull tester: 27G needle, tested at a speed of 1mL/min, and the thrust was 5.68N.

实施例6:酸性条件制备核糖交联胶原蛋白纤维Example 6: Preparation of ribose cross-linked collagen fibers under acidic conditions

步骤(1)-(3)同实施例1。Steps (1) to (3) are the same as in Example 1.

(4)胶原蛋白分子纤维化:取一定体积的纯化后胶原蛋白分子,加入1/10体积的磷酸盐缓冲液(0.2M Na2HPO4:0.2M NaH2PO4=7:3,v:v)。混匀调pH为5.0,30℃放置6小时得到胶原蛋白纤维。70%胶原蛋白纤维直径为15-30nm。(4) Collagen molecule fibrillation: Take a certain volume of purified collagen molecules and add 1/10 volume of phosphate buffer (0.2M Na 2 HPO 4 :0.2M NaH 2 PO 4 =7:3, v:v). Mix well and adjust the pH to 5.0, and place at 30°C for 6 hours to obtain collagen fibers. 70% of the collagen fibers have a diameter of 15-30nm.

(5)胶原蛋白纤维交联:将胶原蛋白纤维离心得到沉淀后,加入10倍体积的1%(w:v)D-核糖-磷酸盐缓冲液,混匀后37℃放置继续搅拌15天。离心收集沉淀,pH7.0磷酸盐缓冲液清洗3次即得核糖交联胶原蛋白纤维。80%核糖交联胶原蛋白纤维直径在150-200nm之间,并形成网状结构。(5) Collagen fiber cross-linking: After the collagen fibers are centrifuged to obtain a precipitate, 10 times the volume of 1% (w:v) D-ribose-phosphate buffer is added, mixed and placed at 37°C for 15 days. The precipitate is collected by centrifugation and washed three times with pH 7.0 phosphate buffer to obtain ribose cross-linked collagen fibers. The diameter of 80% ribose cross-linked collagen fibers is between 150-200 nm and forms a network structure.

步骤(6)同实施例1。Step (6) is the same as in Example 1.

本实施例获得的核糖交联胶原蛋白纤维利用差式扫描量热仪和酶标仪检测,Tm值=59.12℃,交联度46.9%。体外胶原酶处理后降解率56%。进一步通过推拉力试验机检测其物理性能:27G针头,以1mL/min速度进行测试,推力为4.12N。The ribose cross-linked collagen fibers obtained in this example were tested by differential scanning calorimetry and microplate reader, and the Tm value was 59.12°C, and the cross-linking degree was 46.9%. The degradation rate after in vitro collagenase treatment was 56%. The physical properties were further tested by a push-pull tester: 27G needle, tested at a speed of 1mL/min, and the thrust was 4.12N.

实施例7:酸性条件制备核糖交联胶原蛋白纤维Example 7: Preparation of ribose cross-linked collagen fibers under acidic conditions

步骤(1)-(3)同实施例1。Steps (1) to (3) are the same as in Example 1.

(4)胶原蛋白分子纤维化:取一定体积的纯化后胶原蛋白分子,加入1/10体积的磷酸盐缓冲液(0.2M Na2HPO4:0.2M NaH2PO4=7:3,v:v),再加入0.15MNaCl,混匀调pH为5.0。30℃放置6小时得到胶原蛋白纤维。90%胶原蛋白纤维直径为15-30nm。(4) Collagen molecule fibrillation: Take a certain volume of purified collagen molecules, add 1/10 volume of phosphate buffer (0.2M Na2HPO4 : 0.2M NaH2PO4 = 7:3, v:v), then add 0.15M NaCl, mix well and adjust the pH to 5.0. Place at 30°C for 6 hours to obtain collagen fibers. 90% of the collagen fibers have a diameter of 15-30nm.

(5)胶原蛋白纤维交联:将胶原蛋白纤维离心得到沉淀后,加入10倍体积的1%(w:v)D-核糖-磷酸盐缓冲液,混匀后37℃放置继续搅拌15天。离心收集沉淀,pH7.0磷酸盐缓冲液清洗3次即得核糖交联胶原蛋白纤维。80%核糖交联胶原蛋白纤维直径在150-200nm之间,并形成网状结构。(5) Collagen fiber cross-linking: After the collagen fibers are centrifuged to obtain a precipitate, 10 times the volume of 1% (w:v) D-ribose-phosphate buffer is added, mixed and placed at 37°C for 15 days. The precipitate is collected by centrifugation and washed three times with pH 7.0 phosphate buffer to obtain ribose cross-linked collagen fibers. The diameter of 80% ribose cross-linked collagen fibers is between 150-200 nm and forms a network structure.

步骤(6)同实施例1。Step (6) is the same as in Example 1.

本实施例获得的核糖交联胶原蛋白纤维利用差式扫描量热仪和酶标仪检测,Tm值=62.09℃,交联度54.3%。体外胶原酶处理后降解率42%。进一步通过推拉力试验机检测其物理性能:27G针头,以1mL/min速度进行测试,推力为4.32N。The ribose cross-linked collagen fibers obtained in this example were tested by differential scanning calorimetry and microplate reader, with a Tm value of 62.09°C and a cross-linking degree of 54.3%. The degradation rate after in vitro collagenase treatment was 42%. The physical properties were further tested by a push-pull tester: 27G needle, tested at a speed of 1mL/min, with a push force of 4.32N.

实施例8:酸性条件制备核糖交联胶原蛋白纤维Example 8: Preparation of ribose cross-linked collagen fibers under acidic conditions

步骤(1)-(3)同实施例1。Steps (1) to (3) are the same as in Example 1.

(4)胶原蛋白分子纤维化:取一定体积的纯化后胶原蛋白分子,加入1/10体积的磷酸盐缓冲液(0.2M Na2HPO4:0.2M NaH2PO4=7:3,v:v),再加入0.15MNaCl,混匀调pH为5.0。30℃放置6小时得到胶原蛋白纤维。90%胶原蛋白纤维直径为15-30nm。(4) Collagen molecule fibrillation: Take a certain volume of purified collagen molecules, add 1/10 volume of phosphate buffer (0.2M Na2HPO4 : 0.2M NaH2PO4 = 7:3, v:v), then add 0.15M NaCl, mix well and adjust the pH to 5.0. Place at 30°C for 6 hours to obtain collagen fibers. 90% of the collagen fibers have a diameter of 15-30nm.

(5)胶原蛋白纤维交联:将胶原蛋白纤维离心得到沉淀后,加入10倍体积的1%(w:v)D-核糖-磷酸盐缓冲液,混匀后37℃放置继续搅拌12天。离心收集沉淀,pH7.0磷酸盐缓冲液清洗3次即得核糖交联胶原蛋白纤维。80%核糖交联胶原蛋白纤维直径在150-200nm之间,并形成网状结构。(5) Collagen fiber cross-linking: After the collagen fibers are centrifuged to obtain a precipitate, 10 volumes of 1% (w:v) D-ribose-phosphate buffer are added, mixed and placed at 37°C for 12 days. The precipitate is collected by centrifugation and washed three times with pH 7.0 phosphate buffer to obtain ribose cross-linked collagen fibers. The diameter of 80% ribose cross-linked collagen fibers is between 150-200 nm and forms a mesh structure.

步骤(6)同实施例1。Step (6) is the same as in Example 1.

本实施例获得的核糖交联胶原蛋白纤维利用差式扫描量热仪和酶标仪检测,Tm值=60.74℃,交联度52%。体外胶原酶处理后降解率49%。进一步通过推拉力试验机检测其物理性能:27G针头,以1mL/min速度进行测试,推力为3.87N。The ribose cross-linked collagen fibers obtained in this example were tested by differential scanning calorimetry and microplate reader, and the Tm value was 60.74°C, and the cross-linking degree was 52%. The degradation rate after in vitro collagenase treatment was 49%. The physical properties were further tested by a push-pull tester: 27G needle, tested at a speed of 1mL/min, and the thrust was 3.87N.

实施例9:酸性条件制备核糖交联胶原蛋白纤维Example 9: Preparation of ribose cross-linked collagen fibers under acidic conditions

步骤(1)-(3)同实施例1。Steps (1) to (3) are the same as in Example 1.

(4)胶原蛋白分子纤维化:取一定体积的纯化后胶原蛋白分子,加入1/10体积的磷酸盐缓冲液(0.2M Na2HPO4:0.2M NaH2PO4=7:3,v:v),再加入0.15MNaCl混匀调pH为5.0。30℃放置6小时得到胶原蛋白纤维。90%胶原蛋白纤维直径为15-30nm。(4) Collagen fibrosis: Take a certain volume of purified collagen molecules, add 1/10 volume of phosphate buffer (0.2M Na2HPO4 : 0.2M NaH2PO4 = 7 :3, v:v), then add 0.15M NaCl and mix well to adjust the pH to 5.0. Place at 30°C for 6 hours to obtain collagen fibers. 90 % of the collagen fibers have a diameter of 15-30nm.

(5)胶原蛋白纤维交联:将胶原蛋白纤维离心得到沉淀后,加入10倍体积的1%(w:v)D-核糖-磷酸盐缓冲液,混匀后37℃放置继续搅拌10天。离心收集沉淀,pH7.0磷酸盐缓冲液清洗3次即得核糖交联胶原蛋白纤维。80%核糖交联胶原蛋白纤维直径在150-200nm之间,并形成网状结构。(5) Collagen fiber cross-linking: After the collagen fibers are centrifuged to obtain a precipitate, 10 volumes of 1% (w:v) D-ribose-phosphate buffer solution are added, mixed and placed at 37°C for 10 days. The precipitate is collected by centrifugation and washed three times with pH 7.0 phosphate buffer to obtain ribose cross-linked collagen fibers. The diameter of 80% ribose cross-linked collagen fibers is between 150-200 nm and forms a mesh structure.

步骤(6)同实施例1。Step (6) is the same as in Example 1.

本实施例获得的核糖交联胶原蛋白纤维利用差式扫描量热仪和酶标仪检测,Tm值=59.59℃,交联度48.6%。体外胶原酶处理后降解率55%。进一步通过推拉力试验机检测其物理性能:27G针头,以1mL/min速度进行测试,推力为3.74N。The ribose cross-linked collagen fibers obtained in this example were tested by differential scanning calorimetry and microplate reader, with a Tm value of 59.59°C and a cross-linking degree of 48.6%. The degradation rate after in vitro collagenase treatment was 55%. The physical properties were further tested by a push-pull tester: 27G needle, tested at a speed of 1mL/min, with a thrust of 3.74N.

实施例10:酸性条件制备核糖交联胶原蛋白纤维Example 10: Preparation of ribose cross-linked collagen fibers under acidic conditions

步骤(1)-(3)同实施例1。Steps (1) to (3) are the same as in Example 1.

(4)胶原蛋白分子纤维化:取一定体积的纯化后胶原蛋白分子,加入1/10体积的磷酸盐缓冲液(0.2M Na2HPO4:0.2M NaH2PO4=7:3,v:v),再加入0.15MNaCl,混匀调pH为5.0。30℃放置6小时得到胶原蛋白纤维。90%胶原蛋白纤维直径为15-30nm。(4) Collagen molecule fibrillation: Take a certain volume of purified collagen molecules, add 1/10 volume of phosphate buffer (0.2M Na2HPO4 : 0.2M NaH2PO4 = 7:3, v:v), then add 0.15M NaCl, mix well and adjust the pH to 5.0. Place at 30°C for 6 hours to obtain collagen fibers. 90% of the collagen fibers have a diameter of 15-30nm.

(5)胶原蛋白纤维交联:将胶原蛋白纤维离心得到沉淀后,加入10倍体积的3%(w:v)D-核糖-磷酸盐缓冲液,混匀后37℃放置继续搅拌10天。离心收集沉淀,pH7.0磷酸盐缓冲液清洗3次即得核糖交联胶原蛋白纤维。90%核糖交联胶原蛋白纤维直径在150-200nm之间,并形成网状结构。(5) Collagen fiber cross-linking: After the collagen fibers are centrifuged to obtain a precipitate, 10 times the volume of 3% (w:v) D-ribose-phosphate buffer is added, mixed and placed at 37°C for 10 days. The precipitate is collected by centrifugation and washed three times with pH 7.0 phosphate buffer to obtain ribose cross-linked collagen fibers. The diameter of 90% ribose cross-linked collagen fibers is between 150-200 nm and forms a network structure.

步骤(6)同实施例1。Step (6) is the same as in Example 1.

本实施例获得的核糖交联胶原蛋白纤维利用差式扫描量热仪和酶标仪检测,Tm值=66.46℃,交联度56.1%。体外胶原酶处理后降解率39%。进一步通过推拉力试验机检测其物理性能:27G针头,以1mL/min速度进行测试,推力为4.87N。The ribose cross-linked collagen fibers obtained in this example were tested by differential scanning calorimeter and microplate reader, and the Tm value was 66.46°C, and the cross-linking degree was 56.1%. The degradation rate after in vitro collagenase treatment was 39%. The physical properties were further tested by a push-pull tester: 27G needle, tested at a speed of 1mL/min, and the thrust was 4.87N.

实施例11:酸性条件制备核糖交联胶原蛋白纤维Example 11: Preparation of ribose cross-linked collagen fibers under acidic conditions

步骤(1)-(3)同实施例1。Steps (1) to (3) are the same as in Example 1.

(4)胶原蛋白分子纤维化:取一定体积的纯化后胶原蛋白分子,加入1/10体积的磷酸盐缓冲液(0.2M Na2HPO4:0.2M NaH2PO4=7:3,v:v),再加入0.15MNaCl,混匀调pH为5.0。30℃放置6小时得到胶原蛋白纤维。90%胶原蛋白纤维直径为15-30nm。(4) Collagen molecule fibrillation: Take a certain volume of purified collagen molecules, add 1/10 volume of phosphate buffer (0.2M Na2HPO4 : 0.2M NaH2PO4 = 7:3, v:v), then add 0.15M NaCl, mix well and adjust the pH to 5.0. Place at 30°C for 6 hours to obtain collagen fibers. 90% of the collagen fibers have a diameter of 15-30nm.

(5)胶原蛋白纤维交联:将胶原蛋白纤维离心得到沉淀后,加入10倍体积的5%(w:v)D-核糖-磷酸盐缓冲液,混匀后37℃放置继续搅拌10天。离心收集沉淀,pH7.0磷酸盐缓冲液清洗3次即得核糖交联胶原蛋白纤维。90%核糖交联胶原蛋白纤维直径在150-200nm之间,并形成网状结构。(5) Collagen fiber cross-linking: After the collagen fibers are centrifuged to obtain a precipitate, 10 volumes of 5% (w:v) D-ribose-phosphate buffer are added, mixed and placed at 37°C for 10 days. The precipitate is collected by centrifugation and washed three times with pH 7.0 phosphate buffer to obtain ribose cross-linked collagen fibers. The diameter of 90% ribose cross-linked collagen fibers is between 150-200 nm and forms a mesh structure.

步骤(6)同实施例1。Step (6) is the same as in Example 1.

本实施例获得的核糖交联胶原蛋白纤维利用差式扫描量热仪和酶标仪检测,Tm值=59.71℃,交联度50.2%。体外胶原酶处理后降解率47%。进一步通过推拉力试验机检测其物理性能:27G针头,以1mL/min速度进行测试,推力为5.56N。The ribose cross-linked collagen fibers obtained in this example were tested by differential scanning calorimetry and microplate reader, and the Tm value was 59.71°C, and the cross-linking degree was 50.2%. The degradation rate after in vitro collagenase treatment was 47%. The physical properties were further tested by a push-pull tester: 27G needle, tested at a speed of 1mL/min, and the thrust was 5.56N.

以上实施例中,步骤(1)-(3)均相同,主要是对材料进行去脂和灭病毒处理并进行胶原蛋白分子提取及纯化。步骤(4)是对纯化得到的胶原蛋白分子进行纤维化处理,步骤(5)是对胶原蛋白纤维进行核糖交联处理。实施例1-4在中性条件pH7.0进行纤维化处理,之后采用0.5%,1%,2%,5%的D-核糖-磷酸盐缓冲液进行交联处理15天。实施例5、6采用的是酸性条件pH6.0和pH5.0进行纤维化处理,之后采用1%D-核糖-磷酸盐缓冲液进行交联处理15天。实施例7-11采用的是酸性条件pH5.0进行纤维化处理并在纤维化反应溶液:Na2HPO4和NaH2PO4溶液基础上增加了NaCl,之后采用不同浓度D-核糖-磷酸盐缓冲液进行交联处理,其中实施例7-9,采用1%核糖交联15,12,10天;实施例9-11采用1%,3%,5%核糖交联10天。In the above embodiments, steps (1)-(3) are the same, mainly to remove fat and sterilize viruses from the materials and to extract and purify collagen molecules. Step (4) is to perform fibrosis treatment on the purified collagen molecules, and step (5) is to perform ribose cross-linking treatment on the collagen fibers. Examples 1-4 were subjected to fibrosis treatment under neutral conditions of pH 7.0, followed by cross-linking treatment for 15 days using 0.5%, 1%, 2%, and 5% D-ribose-phosphate buffer. Examples 5 and 6 were subjected to fibrosis treatment under acidic conditions of pH 6.0 and pH 5.0, followed by cross-linking treatment for 15 days using 1% D-ribose-phosphate buffer. In Examples 7-11, acidic conditions of pH 5.0 were used for fibrosis treatment and NaCl was added to the fibrosis reaction solution: Na 2 HPO 4 and NaH 2 PO 4 solution. Then, different concentrations of D-ribose-phosphate buffer were used for cross-linking treatment. In Examples 7-9, 1% ribose was used for cross-linking for 15, 12, and 10 days; and in Examples 9-11, 1%, 3%, and 5% ribose were used for cross-linking for 10 days.

所有实施例所得的核糖交联胶原蛋白纤维都进行了熔点,交联度,降解率和推力测量。实施例1-3表明随着核糖的浓度增加,核糖交联胶原蛋白纤维的熔点和交联度提升,胶原酶降解率降低。但是实施例4表明随着核糖的浓度继续增加,交联度和耐胶原酶降解能力反而有所下降,与US 6682769描述的中性条件纤维化后降解率随浓度的变化一致。实施例2,5,6显示在低浓度核糖,酸性条件下所得核糖交联胶原蛋白纤维相比于中性条件所得的核糖交联胶原蛋白纤维,热稳定性,交联度和耐胶原酶降解能力随着pH值的降低而增加,推力随着反应pH值降低而减小。实施例7,8,9表明,酸性条件下在纤维化反应溶液:Na2HPO4和NaH2PO4溶液基础上增加了NaCl,有利于酸性条件下的纤维形成,减少交联时间依旧可以得到高熔点和高交联度的核糖交联胶原蛋白纤维。实施例9,10,11表明,减少交联时间的同时提高核糖浓度,可以增加核糖交联胶原蛋白纤维的交联度和Tm值,耐胶原酶降解能力提高。尤其是实施例10所得核糖交联胶原蛋白纤维效果最好,酸性条件下对胶原蛋白纤维进行单次核糖交联与CN114288469A报道的核糖和碳二亚胺双重交联的效果相当。Tm=66.64℃热稳定性良好且交联度56.1%,耐胶原酶降解能力明显提高;推挤力4.87N,更有利于注射填充;缩短核糖交联反应时间,适合大规模生产制备。The melting point, cross-linking degree, degradation rate and thrust of the ribose cross-linked collagen fibers obtained in all examples were measured. Examples 1-3 show that as the concentration of ribose increases, the melting point and cross-linking degree of the ribose cross-linked collagen fibers increase, and the collagenase degradation rate decreases. However, Example 4 shows that as the concentration of ribose continues to increase, the cross-linking degree and resistance to collagenase degradation decrease, which is consistent with the change in degradation rate with concentration after fibrosis under neutral conditions described in US 6682769. Examples 2, 5, and 6 show that the ribose cross-linked collagen fibers obtained under low ribose concentration and acidic conditions have increased thermal stability, cross-linking degree, and resistance to collagenase degradation as the pH value decreases, and the thrust decreases as the reaction pH value decreases, compared to the ribose cross-linked collagen fibers obtained under neutral conditions. Examples 7, 8, and 9 show that adding NaCl to the fibrosis reaction solution: Na 2 HPO 4 and NaH 2 PO 4 solution under acidic conditions is conducive to fiber formation under acidic conditions, and reducing the cross-linking time can still obtain ribose cross-linked collagen fibers with high melting point and high cross-linking degree. Examples 9, 10, and 11 show that reducing the cross-linking time while increasing the ribose concentration can increase the cross-linking degree and Tm value of the ribose cross-linked collagen fibers, and improve the resistance to collagenase degradation. In particular, the ribose cross-linked collagen fibers obtained in Example 10 have the best effect. The single ribose cross-linking of collagen fibers under acidic conditions is equivalent to the effect of the double cross-linking of ribose and carbodiimide reported in CN114288469A. Tm = 66.64 ° C has good thermal stability and a cross-linking degree of 56.1%, and the resistance to collagenase degradation is significantly improved; the pushing force is 4.87N, which is more conducive to injection filling; the ribose cross-linking reaction time is shortened, and it is suitable for large-scale production and preparation.

中性条件制备的胶原蛋白纤维直径较大,制备的核糖交联胶原蛋白纤维,交联度在30.4-34%之间,Tm值=56.05℃-57.28℃。虽然一定程度上提高了胶原蛋白纤维作为填充剂的维持时间,但耐胶原酶降能力仍无法达到预期。通过实验发现调控纤维化过程和胶原分子组装排列可以提高交联效率和耐胶原酶降解能力,在酸性条件下制备得到直径较小的胶原蛋白纤维,可以充分均匀地与交联剂发生反应,从而提高交联度和熔点。本发明所制备的核糖交联胶原蛋白纤维,交联度在40.7%-56.1%之间,优选48.6%-56.1%,提高了耐胶原酶降解能力;熔点Tm值=58.54℃-66.46℃,优选Tm值=59.59.59℃-66.46℃,具有良好的热稳定性,可以对应到较长的降解周期。这些性能的综合展示,使得本发明所制备的核糖交联胶原蛋白纤维可以作为填充剂配合利多卡因用于整形外科等领域,而且天然核糖作为交联剂制备的交联胶原蛋白纤维填充剂具有较低的推力,大大提升填充剂的生物相容性和使用效果。The diameter of the collagen fiber prepared under neutral conditions is relatively large, and the prepared ribose cross-linked collagen fiber has a cross-linking degree between 30.4% and 34%, and a Tm value of 56.05°C-57.28°C. Although the maintenance time of the collagen fiber as a filler is improved to a certain extent, the ability to resist collagenase degradation still cannot meet expectations. Through experiments, it is found that regulating the fibrosis process and the assembly and arrangement of collagen molecules can improve the cross-linking efficiency and the ability to resist collagenase degradation. Collagen fibers with smaller diameters are prepared under acidic conditions, which can react with the cross-linking agent fully and evenly, thereby improving the degree of cross-linking and melting point. The ribose cross-linked collagen fiber prepared by the present invention has a cross-linking degree between 40.7% and 56.1%, preferably 48.6%-56.1%, which improves the ability to resist collagenase degradation; the melting point Tm value is 58.54°C-66.46°C, preferably Tm value is 59.59.59°C-66.46°C, has good thermal stability, and can correspond to a longer degradation cycle. The comprehensive display of these properties enables the ribose cross-linked collagen fibers prepared by the present invention to be used as a filler in combination with lidocaine in fields such as plastic surgery. In addition, the cross-linked collagen fiber filler prepared using natural ribose as a cross-linking agent has a lower thrust, which greatly improves the biocompatibility and use effect of the filler.

Claims (10)

1.一种核糖交联胶原蛋白纤维,由胶原蛋白纤维以核糖为交联剂交联而成,其特征在于,所述胶原蛋白纤维直径在15-80nm之间;所述核糖交联胶原蛋白纤维直径在150-200nm之间;所述核糖交联胶原蛋白纤维的交联度在40.7%-56.1%之间;Tm值=58.54℃-66.46℃。1. A ribose-crosslinked collagen fiber, which is formed by crosslinking collagen fibers using ribose as a crosslinking agent, characterized in that the diameter of the collagen fibers is between 15-80nm; the diameter of the ribose-crosslinked collagen fibers is between 150-200nm; the crosslinking degree of the ribose-crosslinked collagen fibers is between 40.7%-56.1%; and the Tm value is 58.54℃-66.46℃. 2.权利要求1所述核糖交联胶原蛋白纤维,其特征在于,所述核糖交联胶原蛋白纤维的交联度在48.6%-56.1%之间;Tm值=59.59℃-66.46℃。2. The ribose cross-linked collagen fiber according to claim 1, characterized in that the cross-linking degree of the ribose cross-linked collagen fiber is between 48.6% and 56.1%; and the Tm value is 59.59°C to 66.46°C. 3.权利要求2所述核糖交联胶原蛋白纤维,其特征在于,所述核糖交联胶原蛋白纤维的交联度56.1%;Tm值=66.46℃。3. The ribose cross-linked collagen fiber according to claim 2, characterized in that the cross-linking degree of the ribose cross-linked collagen fiber is 56.1% and the Tm value is 66.46°C. 4.制备权利要求1-3任一所述核糖交联胶原蛋白纤维的方法,其特征在于,包括:猪皮组织经预处理、提取、纯化,得到的去除免疫原性和病毒的纯化胶原蛋白分子在酸性条件下纤维化后,进行核糖交联。4. A method for preparing the ribose-crosslinked collagen fiber according to any one of claims 1 to 3, characterized in that it comprises: pre-treating, extracting and purifying pig skin tissue, and subjecting the obtained purified collagen molecules free of immunogenicity and viruses to fibrosis under acidic conditions, followed by ribose cross-linking. 5.权利要求4所述方法,其特征在于,所述酸性条件pH值5.0-6.0。5. The method according to claim 4, characterized in that the acidic condition has a pH value of 5.0-6.0. 6.权利要求4所述方法,其特征在于,所述核糖质量浓度为1%-5%。6. The method according to claim 4, characterized in that the mass concentration of ribose is 1%-5%. 7.权利要求4所述方法,其特征在于,所述酸性条件为磷酸盐缓冲液,所述胶原蛋白分子为动物源胶原蛋白分子,所述核糖为D-核糖。7. The method according to claim 4, characterized in that the acidic condition is a phosphate buffer, the collagen molecule is an animal-derived collagen molecule, and the ribose is D-ribose. 8.一种交联胶原蛋白纤维填充剂,其特征在于,所述填充剂包含权利要求1-3任一所述核糖交联胶原蛋白纤维。8. A cross-linked collagen fiber filler, characterized in that the filler comprises the ribose cross-linked collagen fiber according to any one of claims 1 to 3. 9.权利要求8所述交联胶原蛋白纤维填充剂,其特征在于,所述填充剂还含有利多卡因。9. The cross-linked collagen fiber filler according to claim 8, characterized in that the filler further contains lidocaine. 10.制备权利要求9所述交联胶原蛋白填充剂的方法,其特征在于,所述方法包括:使用生理盐水调节蛋白浓度35mg/mL,利多卡因浓度0.2%,匀浆后无菌灌装于1mL规格的针管中,密封。10. A method for preparing the cross-linked collagen filler according to claim 9, characterized in that the method comprises: using physiological saline to adjust the protein concentration to 35 mg/mL and the lidocaine concentration to 0.2%, and after homogenization, aseptically filling into a 1 mL syringe and sealing.
CN202410361029.6A 2024-03-27 2024-03-27 Ribose cross-linked collagen fiber, and preparation and application thereof Pending CN118241483A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202410361029.6A CN118241483A (en) 2024-03-27 2024-03-27 Ribose cross-linked collagen fiber, and preparation and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202410361029.6A CN118241483A (en) 2024-03-27 2024-03-27 Ribose cross-linked collagen fiber, and preparation and application thereof

Publications (1)

Publication Number Publication Date
CN118241483A true CN118241483A (en) 2024-06-25

Family

ID=91550557

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202410361029.6A Pending CN118241483A (en) 2024-03-27 2024-03-27 Ribose cross-linked collagen fiber, and preparation and application thereof

Country Status (1)

Country Link
CN (1) CN118241483A (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05105624A (en) * 1991-10-14 1993-04-27 Sangi Co Ltd Reinforced collagen fiber membrane and its preparation
EP0668081A2 (en) * 1994-02-17 1995-08-23 Collagen Corporation Collagen-synthetic polymer conjugates having controlled fiber size distributions
US5955438A (en) * 1994-07-19 1999-09-21 Colbar R & D Ltd. Collagen-based matrix
US20020019516A1 (en) * 2000-04-18 2002-02-14 Matitiau Noff Cross-linked collagen matrices and methods for their preparation
US20080293637A1 (en) * 2007-05-23 2008-11-27 Allergan, Inc. Cross-linked collagen and uses thereof
CN102458493A (en) * 2009-04-28 2012-05-16 比奥马普公司 Novel gum raw material and method for obtaining same
CN107308494A (en) * 2017-07-27 2017-11-03 北京华信佳音医疗科技发展有限责任公司 A kind of injection collagen, preparation method and filler
CN112351800A (en) * 2018-07-02 2021-02-09 美敦力公司 Load bearing aggregated collagen constructs

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05105624A (en) * 1991-10-14 1993-04-27 Sangi Co Ltd Reinforced collagen fiber membrane and its preparation
EP0668081A2 (en) * 1994-02-17 1995-08-23 Collagen Corporation Collagen-synthetic polymer conjugates having controlled fiber size distributions
US5955438A (en) * 1994-07-19 1999-09-21 Colbar R & D Ltd. Collagen-based matrix
US20020019516A1 (en) * 2000-04-18 2002-02-14 Matitiau Noff Cross-linked collagen matrices and methods for their preparation
US20080293637A1 (en) * 2007-05-23 2008-11-27 Allergan, Inc. Cross-linked collagen and uses thereof
CN102458493A (en) * 2009-04-28 2012-05-16 比奥马普公司 Novel gum raw material and method for obtaining same
CN107308494A (en) * 2017-07-27 2017-11-03 北京华信佳音医疗科技发展有限责任公司 A kind of injection collagen, preparation method and filler
CN112351800A (en) * 2018-07-02 2021-02-09 美敦力公司 Load bearing aggregated collagen constructs

Similar Documents

Publication Publication Date Title
CN111217904B (en) A kind of preparation method of polymerized hemoglobin with low polymer content
CN108752604B (en) Soft tissue filling material and preparation method and application thereof
BR0109740B1 (en) PLASMA IgG PRODUCTION METHOD FOR MEDICAL APPLICATIONS
JP2014521415A (en) Composite collagen sponge and method for producing the same
CN111588911B (en) A kind of composite material of slow-release exosome and its preparation method and application
CN107854729A (en) A kind of fibroin albumen base self-healing hydrogel and preparation method thereof
CN117720670B (en) Repeating structural unit recombinant protein ⅢAⅢB-ⅢAⅢBrQTY with self-assembly performance and its application
CN105949300A (en) Method for extracting and separating and purifying protein
JPS6147187A (en) Method of purifying rabies virus
JPS6236326A (en) Remedy for disease of hematopoietic organ
CN100536934C (en) A kind of biological material and preparation method thereof for brain injury repair
CN115739031B (en) Application of chitosan or derivatives thereof in removal of endotoxin in gelatin
WO2025175931A1 (en) Method for preparing streptococcus pneumoniae capsular polysaccharide or degraded polysaccharide thereof
CN118241483A (en) Ribose cross-linked collagen fiber, and preparation and application thereof
CN109731136B (en) Preparation method and application of cartilage inductive matrix material
CN117736344B (en) Recombinant protein IIAIIB-IIAIIB with self-assembly performancerQTYApplication and application thereof
JPH0582367B2 (en)
CN118005772A (en) Preparation method of type II collagen peptide assembly with bone repair activity
CN114524970B (en) A chitosan/silk fibroin sponge loaded with human recombinant bone morphogenetic protein rhBMP-2
CN116808309A (en) A collagen-chitosan composite scaffold and its preparation method and application
CN118241482A (en) Glutaraldehyde cross-linked collagen fibers and their preparation and application
CN118048704A (en) Collagen fiber for water optical needle and preparation and application thereof
CN115998897B (en) Novel concentration-controllable hyaluronic acid biological material and preparation method and application thereof
JP7624256B1 (en) Pharmaceutical composition and method for producing same
JP5758878B2 (en) Purification method of hyaluronic acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination